A Study for the Treatment of Alcohol Dependence

Summary

The Primary objective of this study is to test whether LY2196044 can reduce the number of heavy drinking days per month in people with alcohol dependence. Each subject will undergo a screening and assessment period (including medication washout) prior to randomization into a 16 week double blind treatment period.

Timeline

Start

2008-11

Primary completion

2010-02

Completion

2010-02

Outcome

Missed primary endpoint

registry analysis (unspecified test); LY2196044 vs Placebo; p = 0.120; Mean Difference (Final Values) -4.30 (95% CI -9.72 to 1.13); Mixed Models Analysis NCT00804570 ↗

Drugs

Indications